Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for alopecia are being explored due to the limitations of current options.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Wound healing is complex and requires more research to enhance treatment methods.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

North American ginseng extract helped regrow hair in balding mice.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.